- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Dec 20, 2024
Emerging Company Profile
City: Taking RNAi beyond the liver
Maraganore’s latest RNA company pairs targeting tech with trigger molecules a fraction of the size of Alnylam’s
BioCentury | May 11, 2018
Finance
Amplifying oligos
Five years of preclinical oligo deals show high demand for ASO, siRNA and mRNA
BioCentury | Nov 17, 2016
Translation in Brief
Point taken
Idera's 3GA antisense DNA oligos co-opt the potency and specificity of siRNA
BioCentury | Jun 4, 2015
Distillery Therapeutics
Therapeutics: Argonaute RISC catalytic component 2 (AGO2); fragile X mental retardation autosomal homolog 1 (FXR1)
Items per page:
1 - 9 of 9